Silexion Therapeutics Corp Share Price

NASDAQ: SLXN

Small Cap

$3.52

-0.09

(-2.63%)

Live

as on September 17, 2025 at 12:41 am IST

$₹

Silexion Therapeutics Corp Stock Performance

as on September 17, 2025 at 12:41 am IST

Day's Low
Day's High
$3.44
Day's Price Range
$3.66
$3.52
2.27%
Downside
3.98%
Upside
52 Week's Low
52 Week's High
$3.94
52-Week Price Range
$140.74
$3.52
-11.96%
Downside
3898.22%
Upside

Silexion Therapeutics Corp share price movements today

Previous Close: $3.61
Open: $3.62
Volume: 473.0K
Day's Low - High: $3.44 - $3.66
52 Week Low - High: $3.94 - $140.74

Silexion Therapeutics Corp Historical Returns

1 Month Return: -43.78 %
3 Month Return: -67.77 %
1 Year Return: -96.74 %
3 Year Return: 0 %
5 Year Return: 0 %

Silexion Therapeutics Corp Stock Fundamentals & Key Indicators

Check Silexion Therapeutics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.0M

EPS (TTM)

-12.06

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

217000.00%

Silexion Therapeutics Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Silexion Therapeutics Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Silexion Therapeutics Corp	NA	$3.0M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Silexion Therapeutics Corp Stock including INR - Dollar returns

The Silexion Therapeutics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Silexion Therapeutics Corp investment value today

Current value as on today

₹7,690

Returns

₹92,310

(-92.31%)

Returns from Silexion Therapeutics Corp Stock

₹97,177 (-97.18%)

Dollar Returns*

₹4,867 (+4.87%)

Silexion Therapeutics Corp Stock's Interest Amongst Investors

Search interest for Silexion Therapeutics Corp Stock has increased by 231% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:231% versus previous 30 day period

Silexion Therapeutics Corp Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	0	-	0	0
Operating Income	0	0	0	-1	-1	-1	-8	-1	-1	-2
EBITDA	0	0	0	-1	-1	-1	-8	-5	-1	-2
Interest Expense	-	0	-	0	-	0	0	-	0	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	0	0	0	-1	-1	-1	-11	-1	-1	-2
Income Tax Expense	0	-	0	0	0	0	0	0	-	0
Net Income	0	0	0	-1	-1	-1	-11	-1	-1	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Silexion Therapeutics Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-
Gross Profit	-	-	0
Operating Income	-3	-4	-12
EBITDA	-3	-4	-16
Interest Expense	0	0	0
Depreciation	0	0	0
Income Before Tax	-3	-5	-16
Income Tax Expense	0	0	0
Net Income	-3	-4	16
Net Profit Margin	0.00%	0.00%	0.00%

Silexion Therapeutics Corp Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	0	0	-1	-1	-1	-11	-1	-1	-2
Operating Cash Flow	0	0	-1	-1	-1	-2	-2	-2	-2
Investing Cash Flow	-	0	0	0	-	0	-	0	0
Financing Cash Flow	0	-	-	-	-	2	2	7	0
Change in Cash	0	0	-1	-1	-1	0	0	4	-2

Silexion Therapeutics Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	0	0	-3	-5	-16
Operating Cash Flow	0	-1	-3	-4	-8
Investing Cash Flow	-	-	0	0	0
Financing Cash Flow	0	116	2	0	5
Change in Cash	0	0	-1	-3	-3

Insights on Silexion Therapeutics Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 167.7%
NEGATIVE IMPACT
Price Dip
In the last 7 days, SLXN stock has moved down by -28.7%

About Silexion Therapeutics Corp

Silexion Therapeutics Corp is an Israel-based oncology-focused biotechnology company. The Company is engaged in development of treatments for unsatisfactorily treated solid tumor cancers, which have the mutated KRAS oncogene. The KRAS gene is an oncogene that is involved in regulation of cell division as a result of its ability to relay external signals to the cell nucleus. Based on its research of refractory solid tumor cancers, it is developing a platform focused on the silencing of the KRAS oncogene using ribonucleic acid (RNA)-interference therapeutics. Its lead product candidate, SIL-204B, consists of locally administered small interfering RNAs (siRNA), in an extended-release formulation, as a preferred treatment of locally advanced pancreatic cancer patients, in combination with standard-of-care chemotherapy. Its clinical-stage pipeline is focused on treatment for pancreatic cancer (PC) tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected.

Organisation	Silexion Therapeutics Corp
Headquarters	The Goldyne Savad Inst. of Gene Therapy, Jerusalem, Israel, 9112001
CEO	Mr. Ilan Hadar M.B.A.
E-voting on shares	Click here to vote

Key Management of Silexion Therapeutics Corp

Name	Title
Dr. Mitchell Shirvan M.B.A., Ph.D.	Chief Scientific & Development Officer
Mr. Ilan Hadar M.B.A.	Chairman & CEO
Ms. Mirit Horenshtein Hadar	EVP of Finance Affairs, CFO & Secretary

FAQs

What is Silexion Therapeutics Corp share price today?

Silexion Therapeutics Corp share price today is $3.52 as on September 17, 2025 at 12:41 am IST. Silexion Therapeutics Corp share today touched a day high of $3.66 and a low of $3.44.

What is the 52 week high and 52 week low for Silexion Therapeutics Corp share?

Silexion Therapeutics Corp share touched a 52 week high of $140.74 on September 16, 2024 and a 52 week low of $3.94 on September 12, 2025. Silexion Therapeutics Corp stock price today i.e. September 17, 2025 at 12:41 am IST is trending at $3.52,which is 97.50% down from its 52 week high and -10.68% up from its 52 week low.

What is Silexion Therapeutics Corp's market capitalisation today?

Silexion Therapeutics Corp market capitalisation is $0.00T as on September 17, 2025 at 12:41 am IST.

How to invest in Silexion Therapeutics Corp Stock (SLXN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Silexion Therapeutics Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Silexion Therapeutics Corp Shares that will get you 0.4261 shares as per Silexion Therapeutics Corp share price of $3.52 per share as on September 17, 2025 at 12:41 am IST.

What is the minimum amount required to buy Silexion Therapeutics Corp Stock (SLXN) from India?

Indian investors can start investing in Silexion Therapeutics Corp (SLXN) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 12:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Silexion Therapeutics Corp stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 12:42 am IST). Based on Silexion Therapeutics Corp share’s latest price of $3.52 as on September 17, 2025 at 12:41 am IST, you will get 2.8409 shares of Silexion Therapeutics Corp. Learn more about fractional shares .